Welcome to Shaping Tomorrow

Global Scans · Epilepsy · Weekly Summary


  • [New] The Intersectoral global action plan on epilepsy and other neurological disorders (2022-2031) promotes better access to care and improved quality of life for people with conditions like stroke. World Health Organization: WHO
  • By application, epilepsy accounted for a 56.67% share in 2025, while depression is projected to grow at a 9.75% CAGR through 2031. Mordor Intelligence
  • Expect the FDA to approve specific cannabis-derived medications for particular conditions, similar to how Epidiolex (a CBD medication) was approved for epilepsy. Secret Nature
  • Asia Pacific is emerging as the fastest growing region with a CAGR of 8.21% from 2026 to 2034, owing to the rising prevalence of neurological disorders such as epilepsy, Alzheimer's disease, and stroke-related complications. Straits Research
  • The recent $10 million seed funding round, led by the UCL Technology Fund and Health Technology Holding, underscores not only the confidence in EpilepsyGTx's pioneering research but also in its transformative potential to alleviate the burden of epilepsy globally. The Times Magazine
  • AA Pet Insurance has confirmed the continuation of its sponsorship partnership with the New Zealand Epilepsy Assist Dog Trust in 2024. Insurance Business
  • There will be £45 million of new investment in life sciences, including funding for research into cancer, dementia and epilepsy. NHS Employers

Last updated: 21 June 2026



Please stand by...

The magic is happening, but it might take a couple of minutes.

Login